 SALT LAKE CITY , March 18, 2022 PRNewswire -- Sera Prognostics Inc., The Pregnancy Company Nasdaq: SERA, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report fourth quarter and full year 2021 financial results on Tuesday, March 29, 2022, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. 